PMC7643450_01
Outcomes obtained 12, 44, 62, and 134 days after the completion (the second adipose SVF injection) of treatment of the HGPS patient.
fbioe-08-574010-g002.jpg
PMC7643450_01_fbioe-08-574010-g002.jpg
F2
Total, two IVP injections of adipose SVF were performed on two separate occasions, 1 week apart (Figure 2). About 62 days after the second IVP injection of allogeneic, haploidentical adipose SVF, the patient's blood IGF-1 level increased approximately 50% from 294.0 to 434.9 ng/mL (Figure 2). Consequently, 134 days after the second SVF injection, the HGPS patient noted a 5-cm growth in height and 1.1 kg of weight gain (Figure 2).